Immune reconstitution of systemic sclerosis patients after autologous hematopoietic stem cell transplantation

Autologous hematopoietic stem cell transplantation (AHSCT) has been investigated as treatment for autoimmune diseases. Here, we evaluated immunological mechanisms associated with the therapeutic efficacy of AHSCT in systemic sclerosis(SSc) patients, including TCR repertoire.